JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB109200

Anti-Transglutaminase 2 抗体 [EP2957]

Anti-Transglutaminase 2 antibody [EP2957]

4

(1 Review)

|

(12 Publications)

Rabbit Recombinant Monoclonal Transglutaminase 2 antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 12 publications.

別名を表示する

Protein-glutamine gamma-glutamyltransferase 2, Erythrocyte transglutaminase, Heart G alpha(h), Isopeptidase TGM2, Protein G alpha(h), Protein-glutamine deamidase TGM2, Protein-glutamine dopaminyltransferase TGM2, Protein-glutamine histaminyltransferase TGM2, Protein-glutamine noradrenalinyltransferase TGM2, Protein-glutamine serotonyltransferase TGM2, Tissue transglutaminase, Transglutaminase C, Transglutaminase H, Transglutaminase II, Transglutaminase-2, hhG alpha(h), G(h), tTG, tTgase, TG(C), TGC, TGase C, TGase H, TGase II, TG2, TGase-2, hTG2, TGM2

7 Images
Immunocytochemistry/ Immunofluorescence - Anti-Transglutaminase 2 antibody [EP2957] (AB109200)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-Transglutaminase 2 antibody [EP2957] (AB109200)

ab109200 was shown to react with TGM2 in wild-type A549 cells in immunocytochemistry with loss of signal observed in TGM2 knockout cell line ab261876. Wild-type and knockout cells were mixed and pelleted at a 1 : 1 ratio on coverslips. The cells were fixed with 4% paraformaldehyde (15 min) then permeabilized with 0.1% Triton X-100 (10min) and then blocked with 1x PBS, 0.01% Triton X-100, 5% BSA, 5% NGS. The cells were then incubated with ab109200 at 1/300 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat anti-rabbit secondary antibody to (Alexa Fluor® 555) at 0.5 ?g/ml. Acquisition of the green (wild-type), red (antibody staining) and far-red (knockout) channels was performed. Representative grayscale images of the red channel are shown. Wild-type and knockout cells are outlined with yellow and magenta dashed line, respectively. Schematic representation of the mosaic strategy used is shown on the bottom-right panel. Image was acquired with a Zeiss(LSM-880).

These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

Western blot - Anti-Transglutaminase 2 antibody [EP2957] (AB109200)
  • WB

Lab

Western blot - Anti-Transglutaminase 2 antibody [EP2957] (AB109200)

ab109200 was shown to react with TGM2 in wild-type A549 cells in Western blot with loss of signal observed in TGM2 knockout cell line ab261876. Wild-type A549 and TGM2 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab109200 overnight at 4 °C at a 1/10000 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.

These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

All lanes:

Western blot - Anti-Transglutaminase 2 antibody [EP2957] (ab109200) at 1/10000 dilution

Lane 1:

Wild-type A549 lysate at 40 µg

Lane 2:

Western blot - Human TGM2 (Transglutaminase 2) knockout A549 cell line (<a href='/products/cell-lines/human-tgm2-transglutaminase-2-knockout-a549-cell-line-ab261876'>ab261876</a>) at 40 µg

Observed band size: 75 kDa

false

Western blot - Anti-Transglutaminase 2 antibody [EP2957] (AB109200)
  • WB

Unknown

Western blot - Anti-Transglutaminase 2 antibody [EP2957] (AB109200)

All lanes:

Western blot - Anti-Transglutaminase 2 antibody [EP2957] (ab109200) at 1/10000 dilution

Lane 1:

U87-MG cell lysate at 10 µg

Lane 2:

A549 cell lysate at 10 µg

Lane 3:

HUVEC cell lysate at 10 µg

Predicted band size: 77 kDa

false

Western blot - Anti-Transglutaminase 2 antibody [EP2957] (AB109200)
  • WB

Lab

Western blot - Anti-Transglutaminase 2 antibody [EP2957] (AB109200)

Lanes 1 - 4 : Merged signal (red and green). Green - ab109200 observed at 77 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab109200 was shown to recognize TGM2 in wild-type A549 cells as signal was lost at the expected MW in TGM2 knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and TGM2 knockout samples were subjected to SDS-PAGE. The membrane was blocked with 3% Milk. ab109200 and ab8245 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/10000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Transglutaminase 2 antibody [EP2957] (ab109200) at 1/1000 dilution

Lane 1:

Wild-type A549 whole cell lysate at 20 µg

Lane 2:

TGM2 knockout A549 whole cell lysate at 20 µg

Lane 3:

HeLa whole cell lysate at 20 µg

Lane 4:

HUVEC whole cell lysate at 20 µg

Predicted band size: 77 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Transglutaminase 2 antibody [EP2957] (AB109200)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Transglutaminase 2 antibody [EP2957] (AB109200)

ab109200, at 1/100 dilution, staining Transglutaminase 2 in paraffin-embedded Human kidney tissue by Immunohistochemistry.

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Western blot - Anti-Transglutaminase 2 antibody [EP2957] (AB109200)
  • WB

Lab

Western blot - Anti-Transglutaminase 2 antibody [EP2957] (AB109200)

Lanes 1-2 : Merged signal (red and green). Green - ab109200 observed at 77 kDa. Red - loading control ab8245 observed at 37 kDa.

ab109200 Anti-Transglutaminase 2 antibody [EP2957] was shown to specifically react with Transglutaminase 2 in wild-type A549 cells. Loss of signal was observed when knockout cell line ab267110 (knockout cell lysate ab257087) was used. Wild-type and Transglutaminase 2 knockout samples were subjected to SDS-PAGE. ab109200 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 10000 and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Transglutaminase 2 antibody [EP2957] (ab109200) at 1/10000 dilution

Lane 1:

Wild-type A549 cell lysate at 20 µg

Lane 2:

TGM2 knockout A549 cell lysate at 20 µg

Predicted band size: 77 kDa

Observed band size: 77 kDa

false

Western blot - Anti-Transglutaminase 2 antibody [EP2957] (AB109200)
  • WB

Lab

Western blot - Anti-Transglutaminase 2 antibody [EP2957] (AB109200)

Lanes 1-4 : Merged signal (red and green). Green - ab109200 observed at 77 kDa. Red - loading control ab8245 observed at 37 kDa.

ab109200 Anti-Transglutaminase 2 antibody [EP2957] was shown to specifically react with Transglutaminase 2 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265245 (knockout cell lysate ab257085) was used. Wild-type and Transglutaminase 2 knockout samples were subjected to SDS-PAGE. ab109200 and Anti-alpha Tubulin antibody [EP1332Y] - Microtubule Marker (ab52866) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Transglutaminase 2 antibody [EP2957] (ab109200) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

TGM2 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human TGM2 (Transglutaminase 2) knockout HeLa cell line (<a href='/products/cell-lines/human-tgm2-transglutaminase-2-knockout-hela-cell-line-ab265245'>ab265245</a>)

Lane 3:

Wild-type A549 cell lysate at 20 µg

Lane 4:

TGM2 knockout A549 cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution

Predicted band size: 77 kDa

Observed band size: 77 kDa

false

関連する標識済み抗体及び組成の異なる製品 (1)

  • Carrier free

    Anti-Transglutaminase 2 antibody [EP2957] - BSA and Azide free

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EP2957

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

ICC/IF, WB, IHC-P

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/250", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/50000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/10000", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

下記製品にもご興味をお持ちいただけるかもしれません:

AB283882

Human Transglutaminase 2 ELISA Kit

1

1 Reviews

製品ページを見る
こちらの製品も推奨する理由

この製品は、同様の実験や関連する研究で広く使用されていることから推奨させていただいております。

お客様の実験に適するかご確認いただくため、必ず製品データシートをご確認いただくことをお勧めいたします。ご不明点等ございましたら、テクニカルサポートチームまでお問い合わせください。

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
-20°C
保管に関する情報
Stable for 12 months at -20°C

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Transglutaminase 2 also known as TG2 or tissue transglutaminase is an enzyme with a mass of approximately 74 kDa. It catalyzes the formation of covalent bonds by crosslinking glutamine residues and lysine residues in proteins. This enzyme is widely expressed in various tissues including the liver heart and lungs. It can act as a GTPase a kinase and a protein disulfide isomerase highlighting its multifunctional nature. Additionally transglutaminase 2 associates with cell membranes cytoskeleton and extracellular matrix indicating its versatile involvement in cellular processes.
Biological function summary

Transglutaminase 2 plays roles in cell adhesion wound healing and the immune response. It mediates extracellular matrix stabilization through crosslinking structural proteins which is critical for tissue repair. The enzyme does not typically form a stable part of a large complex but interacts with fibronectin as a binding partner highlighting its role in cellular adhesion and migration. The enzymatic activity of transglutaminase 2 helps maintain tissue integrity by modifying extracellular and intracellular proteins.

Pathways

Transglutaminase 2 contributes significantly to the integrin-mediated signaling pathway and the apoptosis pathway. It assists in the modulation of cell-matrix interactions by crosslinking matrix proteins which is important for integrin signaling. During apoptosis transglutaminase 2 promotes cellular processes that lead to cell death via its involvement in nuclear condensation and DNA fragmentation. In these pathways proteins such as fibronectin and integrins interact with transglutaminase 2 facilitating its regulatory functions.

Transglutaminase 2 is associated with celiac disease and neurodegenerative disorders like Huntington's disease. Its autoantigenic properties make it a target in celiac disease where antibodies against transglutaminase 2 play a role in the pathology by affecting intestinal tissue. In Huntington's disease transglutaminase 2 contributes to the formation of protein aggregates which are toxic to neurons. This enzyme's interactions with proteins such as gliadin in celiac disease and huntingtin in Huntington's disease are central to its pathogenic mechanism.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Calcium-dependent acyltransferase that catalyzes the formation of covalent bonds between peptide-bound glutamine and various primary amines, such as gamma-amino group of peptide-bound lysine, or mono- and polyamines, thereby producing cross-linked or aminated proteins, respectively (PubMed : 23941696, PubMed : 31991788, PubMed : 9252372). Involved in many biological processes, such as bone development, angiogenesis, wound healing, cellular differentiation, chromatin modification and apoptosis (PubMed : 1683874, PubMed : 27270573, PubMed : 28198360, PubMed : 7935379, PubMed : 9252372). Acts as a protein-glutamine gamma-glutamyltransferase by mediating the cross-linking of proteins, such as ACO2, HSPB6, FN1, HMGB1, RAP1GDS1, SLC25A4/ANT1, SPP1 and WDR54 (PubMed : 23941696, PubMed : 24349085, PubMed : 29618516, PubMed : 30458214). Under physiological conditions, the protein cross-linking activity is inhibited by GTP; inhibition is relieved by Ca(2+) in response to various stresses (PubMed : 18092889, PubMed : 7592956, PubMed : 7649299). When secreted, catalyzes cross-linking of proteins of the extracellular matrix, such as FN1 and SPP1 resulting in the formation of scaffolds (PubMed : 12506096). Plays a key role during apoptosis, both by (1) promoting the cross-linking of cytoskeletal proteins resulting in condensation of the cytoplasm, and by (2) mediating cross-linking proteins of the extracellular matrix, resulting in the irreversible formation of scaffolds that stabilize the integrity of the dying cells before their clearance by phagocytosis, thereby preventing the leakage of harmful intracellular components (PubMed : 7935379, PubMed : 9252372). In addition to protein cross-linking, can use different monoamine substrates to catalyze a vast array of protein post-translational modifications : mediates aminylation of serotonin, dopamine, noradrenaline or histamine into glutamine residues of target proteins to generate protein serotonylation, dopaminylation, noradrenalinylation or histaminylation, respectively (PubMed : 23797785, PubMed : 30867594). Mediates protein serotonylation of small GTPases during activation and aggregation of platelets, leading to constitutive activation of these GTPases (By similarity). Plays a key role in chromatin organization by mediating serotonylation and dopaminylation of histone H3 (PubMed : 30867594, PubMed : 32273471). Catalyzes serotonylation of 'Gln-5' of histone H3 (H3Q5ser) during serotonergic neuron differentiation, thereby facilitating transcription (PubMed : 30867594). Acts as a mediator of neurotransmission-independent role of nuclear dopamine in ventral tegmental area (VTA) neurons : catalyzes dopaminylation of 'Gln-5' of histone H3 (H3Q5dop), thereby regulating relapse-related transcriptional plasticity in the reward system (PubMed : 32273471). Regulates vein remodeling by mediating serotonylation and subsequent inactivation of ATP2A2/SERCA2 (By similarity). Also acts as a protein deamidase by mediating the side chain deamidation of specific glutamine residues of proteins to glutamate (PubMed : 20547769, PubMed : 9623982). Catalyzes specific deamidation of protein gliadin, a component of wheat gluten in the diet (PubMed : 9623982). May also act as an isopeptidase cleaving the previously formed cross-links (PubMed : 26250429, PubMed : 27131890). Also able to participate in signaling pathways independently of its acyltransferase activity : acts as a signal transducer in alpha-1 adrenergic receptor-mediated stimulation of phospholipase C-delta (PLCD) activity and is required for coupling alpha-1 adrenergic agonists to the stimulation of phosphoinositide lipid metabolism (PubMed : 8943303).. Isoform 2. Has cytotoxic activity : is able to induce apoptosis independently of its acyltransferase activity.
See full target information Protein-glutamine gamma-glutamyltransferase 2

文献 (12)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in molecular biosciences 9:879461 PubMed35669563

2022

Identification of a Diagnostic Signature and Immune Cell Infiltration Characteristics in Keloids.

Applications

Unspecified application

Species

Unspecified reactive species

Yijun Xia,Youbin Wang,Yingjie Xiao,Mengjie Shan,Yan Hao,Lingyun Zhang

Molecular medicine reports 24: PubMed34549308

2021

miR‑125a‑5p reverses epithelial‑mesenchymal transition and restores drug sensitivity by negatively regulating TAFAZZIN signaling in breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Dongmei Li,Limei Chen,Xiaofang Zhang,Yanhua Wang,Chuansheng Huang,Jianglong Li,Feilong He,Wenxing He

Frontiers in oncology 11:610547 PubMed33738254

2021

The /miR-491 Axis Modulates Papillary Thyroid Cancer Invasion and Metastasis Through TGM2/NFκb/FN1 Signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Sun,Yuan Qin,Zhihong Wang,Wenwu Dong,Liang He,Ting Zhang,Hao Zhang

Journal of pharmaceutical sciences 110:239-250 PubMed33159915

2020

Proteomics-Informed Identification of Luminal Targets For In Situ Diagnosis of Inflammatory Bowel Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Shno Asad,Christine Wegler,David Ahl,Christel A S Bergström,Mia Phillipson,Per Artursson,Alexandra Teleki

Evolutionary applications 13:2689-2703 PubMed33294017

2020

Collagen production and niche engineering: A novel strategy for cancer cells to survive acidosis in DCIS and evolve.

Applications

Unspecified application

Species

Unspecified reactive species

Mehdi Damaghi,Hidetoshi Mori,Samantha Byrne,Liping Xu,Tingan Chen,Joseph Johnson,Nathan D Gallant,Andriy Marusyk,Alexander D Borowsky,Robert J Gillies

Bulletin of mathematical biology 82:15 PubMed31953602

2020

Mix and Match: Phenotypic Coexistence as a Key Facilitator of Cancer Invasion.

Applications

Unspecified application

Species

Unspecified reactive species

Maximilian A R Strobl,Andrew L Krause,Mehdi Damaghi,Robert Gillies,Alexander R A Anderson,Philip K Maini

Parasites & vectors 12:302 PubMed31200771

2019

Contribution of tissue transglutaminase to the severity of hepatic fibrosis resulting from Schistosoma japonicum infection through the regulation of IL-33/ST2 expression.

Applications

Unspecified application

Species

Unspecified reactive species

Zhi-Yong Li,LinZhuo Xiao,GuiYing Lin,JuanJuan Tang,YuQiang Chen,Lan Chen,BaoQi Li,MeiLing Wu,ShuYan Liu,ChuQin Huang,Dominique Ferrandon,Zi Li

Methods in molecular biology (Clifton, N.J.) 1967:263-274 PubMed31069776

2019

In Vivo Measurement of Redox-Regulated TG2 Activity.

Applications

Unspecified application

Species

Unspecified reactive species

Arek V Melkonian,Nielson Weng,Brad A Palanski,Chaitan Khosla

The FEBS journal 285:3056-3076 PubMed29935061

2018

Targeting transglutaminase 2 partially restores extracellular matrix structure but not alveolar architecture in experimental bronchopulmonary dysplasia.

Applications

Unspecified application

Species

Unspecified reactive species

Ivana Mižíková,Tilman Pfeffer,Claudio Nardiello,David E Surate Solaligue,Heiko Steenbock,Hideki Tatsukawa,Diogo M Silva,István Vadász,Susanne Herold,Richard J Pease,Siiri E Iismaa,Kiyotaka Hitomi,Werner Seeger,Jürgen Brinckmann,Rory E Morty

Cell death & disease 9:579 PubMed29785022

2018

Novel peptide GX1 inhibits angiogenesis by specifically binding to transglutaminase-2 in the tumorous endothelial cells of gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Zhijie Lei,Na Chai,Miaomiao Tian,Ying Zhang,Guodong Wang,Jian Liu,Zuhong Tian,Xiaofang Yi,Di Chen,Xiaowei Li,Pengfei Yu,Hao Hu,Bing Xu,Chao Jian,Zhenyuan Bian,Hao Guo,Jinpeng Wang,Shiming Peng,Yongzhan Nie,Niu Huang,Sijun Hu,Kaichun Wu
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

関連製品

Select an associated product type
Alternative Product
Primary Antibodies

AB137378

Anti-Transglutaminase 2 antibody

primary-antibodies

transglutaminase-2-antibody-ab137378

0

(0 reviews)

Alternative Product
Primary Antibodies

AB212882

Anti-Transglutaminase 2 antibody [TGM2/419] - BSA and Azide free

primary-antibodies

transglutaminase-2-antibody-tgm2-419-bsa-and-azide-free-ab212882

0

(0 reviews)

Alternative Product
Primary Antibodies

AB183539

Anti-Transglutaminase 2 antibody - C-terminal

primary-antibodies

transglutaminase-2-antibody-c-terminal-ab183539

0

(0 reviews)

Alternative Product
Primary Antibodies

AB2386

Anti-Transglutaminase 2 antibody [CUB 7402]

primary-antibodies

transglutaminase-2-antibody-cub-7402-ab2386

5

(9 reviews)

Alternative Product
Primary Antibodies

AB216018

Anti-Transglutaminase 2 antibody [TGM2/419]

primary-antibodies

transglutaminase-2-antibody-tgm2-419-ab216018

0

(0 reviews)

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com